Drug
Rotigaptide clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2005
How studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2005 (2)
| Year | Studies |
|---|---|
| 2005 | 2 |
| 2009 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 1
Wyeth is now a wholly owned subsidiary of Pfizer (2) · University of Edinburgh (1)
Studies
Open first, then newest update. How each study uses rotigaptide is read from its arms, and is right about nine times in ten.
Testing it · 3
- Gap Junction Potentiation of Endothelial Function With RotigaptideCompletedNot applicableUniversity of EdinburghNCT00901563Written as Rotigaptide
- Study Evaluating GAP-486 on Heart Rhythm in Patients With Coronary Artery DiseaseTerminatedPhase 2Wyeth is now a wholly owned subsidiary of PfizerNCT00137332Written as GAP-486 (ZP-123)
- Study Evaluating GAP-486 in Heart RhythmTerminatedPhase 2Wyeth is now a wholly owned subsidiary of PfizerNCT00137293Written as GAP-486 (ZP-123)
Codes
What other systems call rotigaptide · ClinicalTrials.gg INT004561
- MeSH (NLM) C477643rotigaptideOne source NLM
- UNII (FDA) GFA1W6KO7NROTIGAPTIDEConfirmed FDA, NLM, Wikidata
- Wikidata Q7370547rotigaptideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C152260RotigaptideOne source FDA
- DrugBank DB13067One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C477643 | rotigaptide | One source NLM |
| UNII (FDA) | GFA1W6KO7N | ROTIGAPTIDE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q7370547 | rotigaptide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C152260 | Rotigaptide | One source FDA |
| DrugBank | DB13067 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.